JSM 2005 - Toronto

JSM Activity #53

This is the preliminary program for the 2005 Joint Statistical Meetings in Minneapolis, Minnesota. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 7-10, 2005); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.



The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

The Program has labeled the meeting rooms with "letters" preceding the name of the room, designating in which facility the room is located:

Minneapolis Convention Center = “MCC” Hilton Minneapolis Hotel = “H” Hyatt Regency Minneapolis = “HY”

Back to main JSM 2005 Program page
Legend: = Applied Session, = Theme Session, = Presenter
Add To My Program
53 Sun, 8/7/05, 4:00 PM - 5:50 PM MCC-200 H
ROC Methods in Diagnostic Device Evaluation - Topic Contributed - Papers
Section on Statistics in Epidemiology, Biopharmaceutical Section, WNAR
Organizer(s): Peter Lam, Boston Scientific Corporation, Michael Lu, Edwards Lifesciences
Chair(s): Hollington Lu, U.S. Food and Drug Administration
     4:05 PM   Receiver Operating Characteristic (ROC) Curve for Demographic Variable Dependent Diagnostic Method — Michael Lu, Edwards Lifesciences; Victoria Petrides , Abbott Laboratories
     4:25 PM   Analysis of Multireader, Multitest Receiver Operating Characteristic (ROC) Curves — Xiao-Hua (Andrew) Zhou, University of Washington; Xiao Song, University of Washington
     4:45 PM   Receiver Operating Characteristic Curve Method for Surrogate Endpoints for Predicting Target Lesion Revascularization in TAXUS Stent Clinical Trials — Hong Wang, Boston Scientific Corporation; Peter Lam, Boston Scientific Corporation; Joerg Koglin, Boston Scientific Corporation; Mary Russell, Boston Scientific Corporation
     5:05 PM   The Role of Late Loss in Predicting Target Lesion Revascularization (TLR) in TAXUS Stented Coronary Lesions — Zheng (Frank) Zhou, Boston Scientific Corporation; Yongyi Yu, Boston Scientific Corporation; Peter Lam, Boston Scientific Corporation
     5:25 PM   Establishment of a Surrogate Marker Application to Cardiovascular Drug Eluting Stent Trial — Roseann White, Guidant Corporation
     5:45 PM   Floor Discussion
 

JSM 2005 For information, contact jsm@amstat.org or phone (888) 231-3473. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2005